Our Services & Solutions

We offer all services and analytics required to evaluate life science assets.

Financial Asset Valuation

Our Financial Asset Valuation includes

  • determination of project-related cash in- and outflows, including R&D, marketing and production related costs,
  • probability adjustment of cash flows,
  • identification of a company’s cost of capital,
  • calculation of expected (‘risk-adjusted’) net present value (‘eNPVs’),
  • calculation of expected value increase upon reaching pre-defined milestones,
  • search for ‘comparables’ (e.g., market values, financial terms of licensing deals and M&A transactions).

Bioscience Valuation emphasizes assessment validity and quality as well as a clear communication of value.